A subscription to JoVE is required to view this content. Sign in or start your free trial.

Case Report

Laparoscopic Radical Resection for Hilar Cholangiocarcinoma with Portal Vein Invasions

446 views

DOI:

10.3791/69311

November 14th, 2025

In This Article

Summary

Here, we present a protocol for laparoscopic radical resection and vascular reconstruction of hilar cholangiocarcinoma with portal vein invasion, providing reproducible surgical guidance for clinical practice.

Abstract

Laparoscopic radical resection for hilar cholangiocarcinoma with vascular invasion is technically demanding but feasible in selected cases when performed by an experienced hepatobiliary surgical team. Precise minimally invasive technical execution and systematic surgical workflow organization are critical for mitigating surgical risks. We present a patient with Bismuth type IV HCCA with portal vein invasion who underwent a fully laparoscopic radical resection. The key surgical steps were as follows: (1) "en bloc" resection of hilar lymph nodes and the perihilar neural plexus; (2) segmental resection of the invaded portal vein followed by continuous suture reconstruction; and (3) microsurgical plasty of multiple bile duct orifices in conjunction with Roux-en-Y hepaticojejunostomy. The surgery was completed in 6 h, with an estimated blood loss of 200 mL and without conversion to open laparotomy. Postoperative pathological examination confirmed R0 resection with no lymph node metastases. No postoperative complications, including biliary leakage, haemorrhage, or infection, occurred. The patient remains under surveillance. Follow-up occurred at 1 month and 3 months after surgery, and subsequently occurs every 3 months. Assessments include liver function tests, tumour marker assays, and imaging (ultrasound, CT, or MRI).

Introduction

Cholangiocarcinoma is a highly heterogeneous malignancy originating from the epithelial cells of the bile ducts and gallbladder1; hilar cholangiocarcinoma accounts for approximately 10%-15% of all primary liver cancers, second only to hepatocellular carcinoma2. Owing to the high degree of malignancy and strong invasiveness of this disease, despite the gradual increase in diagnostic and therapeutic regimens, the overall survival and quality of life of patients remain unsatisfactory. R0 surgical resection is widely recognized as the only potentially curative treatment modality to achieve optimal long-term survival rates3,4. Recent advancements in laparoscopic surgery have increased surgeons' confidence in managing hilar cholangiocarcinoma. Li Jun et al. reported that the application of laparoscopic techniques in the surgical treatment of perihilar cholangiocarcinoma is a safe option5,6. Studies have suggested that laparoscopic radical resection and robotic surgery are comparable to open radical resection in terms of safety and radicality, and better therapeutic effects can be achieved by selecting appropriate cases7,8,9. In experienced centres, the resectability rate is as high as 75%10. Overall, laparoscopic surgery offers several advantages, including a reduced occurrence of complications and a shorter recovery time. However, there are few reports on hilar cholangiocarcinoma with portal vein invasion, and no guidelines or consensus have been formed. In this case, the operation was completed through en bloc resection of the hilar lymph nodes and plexus, continuous suture reconstruction after resection of the invading portal vein, and microplasty of multiple bile duct openings, combined with a Roux-en-Y choledochojejunostomy, all under total laparoscopy. This case offers insights and solutions for the application of laparoscopic radical resection in patients with hilar cholangiocarcinoma and portal vein invasion.

Case presentation
A 69-year-old male was admitted to the hospital due to tea-coloured urine and a loss of appetite for more than 20 days without an obvious cause. A comprehensive abdominal ultrasound examination suggested a possible cholangiocarcinoma. He had taken self-administered medications such as Jinqiancao granules, but the symptoms did not improve significantly. He had a 15-year history of type 2 diabetes, which was controlled with metformin, dapagliflozin, and acarbose. There was no history of infectious diseases or surgeries. Physical examination revealed jaundice of the skin and sclera; no obvious tenderness, rebound tenderness, or muscular tension was found in the abdomen.

Diagnosis, assessment, and plan
Diagnostic assessment revealed elevated Carbohydrate Antigen 19-9 (CA19-9) levels at 146.5 U/mL and Carcinoembryonic Antigen (CEA) levels at 3.5 ng/mL, with liver function classified as Child-Pugh grade B. Preoperative imaging via enhanced upper abdominal computed tomography (CT) and magnetic resonance imaging (MRI) confirmed suspected hilar cholangiocarcinoma with probable vascular invasion and lymph node metastasis (Figure 1). The patient was diagnosed with hilar cholangiocarcinoma. The surgical plan comprised laparoscopic radical resection for hilar cholangiocarcinoma. This involved en bloc resection of hilar lymph nodes and the perineural plexus, followed by segmental portal vein resection with continuous suture anastomosis. The procedure concluded with microsurgical reconstruction of multiple biliary ducts and Roux-en-Y hepaticojejunostomy.

Access restricted. Please log in or start a trial to view this content.

Protocol

​The operation followed standard procedures and received ethics approval. This study was approved by the Ethics Committee of the First Affiliated Hospital of Chongqing Medical University. Informed written consent was obtained from the patient. The reagents and the equipment used are listed in the Table of Materials.

1. Preoperative preparation

  1. Patient preparation: Following induction of general anesthesia with endotracheal intubation, the patient was positioned in a modified supine posture: 30° right tilt with a reverse Trendelenburg orientation (head elevated 20°, feet lowered).
    NOTE: Standard preoperative interventions included nasogastric tube placement for gastrointestinal decompression, urinary catheterization, and central venous catheterization. The abdominal operative field was prepared with an antiseptic solution and sterile draping. Ensure the availability of the robotic system and robotic instruments.
  2. Trocar Placement: A 10-mm vertical incision was created 1 cm right of the umbilicus using a scalpel, and a 10-mm trocar was inserted as the observation port. The insufflation tube was connected to the a 10 mm trocar to establish pneumoperitoneum (with a pressure of 14 mmHg). Under direct visualization, the following working ports were established:
    1. a 5-mm trocar at the right subcostal point (1 cm inferior to the intersection of the right midclavicular line and costal margin);
    2. a 12-mm trocar at the left subcostal point (1 cm inferior to the intersection of the left midclavicular line and costal margin);
    3. two 12-mm trocars positioned bilaterally in the supraumbilical region (immediately superior to the umbilicus);
      ​NOTE: The surgeon operated from the patient's right side with the assistant positioned contralaterally, and the laparoscope was maintained in the umbilical observation port. It was worth noting that the layout of the trocars and the position of the observation port could be appropriately adjusted according to the location, size, and other conditions of the lesion.

2. Surgical procedure

  1. Abdominal exploration: A full abdominal exploration was performed using laparoscopy to observe the shape, size, texture, and other characteristics of the liver, gallbladder, and common bile duct, and assess for the presence of intra-abdominal metastatic lesions. No ascites or omental adhesions were observed.
    ​NOTE: The liver exhibited cholestatic changes without evidence of masses. The gallbladder measured approximately 6 × 4 × 3 cm in size, and the common bile duct had a diameter of approximately 0.8 cm. The stomach, small intestine, and large intestine appeared unremarkable.
  2. Cholecystectomy: An electrocoagulation hook was used to dissect the adhesions between the gallbladder and the greater omentum to expose the gallbladder. Calot's triangle was carefully dissected to isolate the cystic artery and cystic duct.
    1. Absorbable ligating clips were applied to both the proximal and distal ends of these structures, which were then transected using curved scissors. The gallbladder was subsequently removed from the gallbladder fossa via a combined antegrade and retrograde approach.
      NOTE: The Calot's triangle is constituted by the common hepatic duct, cystic duct, and cystic artery.
  3. En-bloc dissection of the hilar lymph nodes and nerve plexuses: An ultrasonic scalpel was used to dissect, mobilize, and suspend the portal vein (PV). The extrahepatic bile duct and lymph node groups 8, 12, 12p, and 13 en bloc were removed along the PV towards the hepatic hilum, achieving skeletonization of the hepatoduodenal ligament (Figure 2).
  4. Dissection of the first hepatic hilum and portal vein reconstruction: The tumour was found to be slightly adherent to the right hepatic artery, with invasion of the left branch of the portal vein. The main portal vein and its right branch were clamped, followed by sharp transection of the left portal vein, which was then repaired (Figure 3).
  5. Biliary tract biopsy: The inferior margin of the common bile duct was transected, and an intraoperative frozen section examination was performed on the stump, with no tumour growth observed at the resection margin. The right hepatic duct was transected up to the right anterior hepatic duct and right posterior hepatic duct, ensuring that the intraoperative frozen section results of the resection margins were negative. The hilar bile ducts were shaped (Figure 4).
  6. Caudate lobectomy combined with left hemihepatectomy: The left hemiliver was mobilized by dividing the falciform, left triangular, and left coronary ligaments. Following skeletonization of the hepatoduodenal ligament, the left hepatic artery and left portal vein were ligated and divided, achieving devascularization of the left hemiliver (including the caudate lobe) with clear demarcation.
    1. Parenchymal transection was performed along the predefined plane using an ultrasonic scalpel until reaching the second hepatic hilum. The left hepatic vein was then divided with a blue cartridge stapler, and the left hemiliver, along with the caudate lobe, was completely removed (Figure 5).
  7. Microplasty of multiple bile duct orifices combined with Roux-en-Y biliary-enteric anastomosis: After the hilar bile ducts were shaped, the jejunum was transected using a stapler (one white load). The distal end was anastomosed to the lateral wall of the bile duct via a side-to-side biliary-enteric anastomosis anterior to the colon.
    1. At a distance of 50 cm from the biliary-enteric anastomosis, an enter-enteric anastomosis was performed using a stapler (one white load). The seromuscular layer was sutured with a barbed suture (Figure 6).
  8. Drain placement: After haemostasis was achieved with an ablation electrode, a total of 3 drainage tubes were placed at Winslow's foramen and the left hepatic transection surface.
  9. Postoperative care
    1. ERAS postoperative management: Early oral intake and early ambulation were implemented to promote the recovery of gastrointestinal function and physical rehabilitation, thereby reducing postoperative complications and improving patients' quality of life.
    2. Nutritional support: Measures were taken to facilitate gastrointestinal recovery, and a multidisciplinary consultation was conducted to formulate an individualized treatment plan.
    3. Prevention and treatment of complications: Dynamic monitoring of bilirubin, albumin, and haemoglobin; biochemical analysis of drainage fluid; and bacterial culture were performed.

Access restricted. Please log in or start a trial to view this content.

Results

In this case report, total laparoscopic radical resection was successfully performed for Bismuth type IV hilar cholangiocarcinoma with portal vein invasion. Postoperative pathology confirmed R0 resection. The operation duration was 6 h, with 200 mL of intraoperative blood loss and without conversion to laparotomy (Table 1). Upon discharge, a re-examination of liver function revealed that the total bilirubin level was less than 30 µmol/L and the ALT level was less than 50 ...

Access restricted. Please log in or start a trial to view this content.

Discussion

HCCA is a prevalent malignancy of the biliary tract, constituting approximately 50% of all biliary tract malignancies11. Radical resection remains the sole potentially curative therapeutic modality. While traditional open surgery facilitates R0 resection under direct visualization, it necessitates a large incision, entails a prolonged recovery period, and is associated with a relatively high risk of multiple complications, consequently leading to extended hospital stays12

Access restricted. Please log in or start a trial to view this content.

Materials

List of materials used in this article
NameCompanyCatalog NumberComments
Ablation electrode (multifunctional surgical dissector)Nanchang Huaan CompanyB1Sterile, ethylene oxide sterilized, disposable
Alligaclip Absorbable Ligating ClipCovidien8886848813Sterile, ethylene oxide sterilized, disposable
Barbed sutureCovidien3-0/4-0Sterile, ethylene oxide sterilized, disposable
Disposable non-absorbable ligating clipsBeijing Bohui CompanyRJLK-S/RJLK-MSterile, ethylene oxide sterilized, disposable
Disposable staple cartridge 60Tianjin Ruiqi CompanySRC60Sterile, ethylene oxide sterilized, disposable
Electric laparoscopic linear cutting stapler and staple cartridgeJohnson (USA)PSEE60ASterile, ethylene oxide sterilized, disposable
TrocarSurgaid Medical?Xiamen?Co., LtdNPCM-100-12;NPVM-100-3-CSterile, ethylene oxide sterilized, disposable

References

  1. Ilyas, S. I., Gores, G. J. Pathogenesis, diagnosis, and management of cholangiocarcinoma. Gastroenterology. 145, 1215-1229 (2013).
  2. Cho, S. M., Esmail, A., Raza, A., Dacha, S., Abdelrahim, M. Timeline of FDAapproved targeted therapy for cholangiocarcinoma. Cancers (Basel). 14 (11), 2641(2022).
  3. Yu, G., et al. PKM2 regulates neural invasion of and predicts poor prognosis for human hilar cholangiocarcinoma. Mol Cancer. 14, 193(2015).
  4. Sapisochin, G., et al. Multidisciplinary treatment for hilar and intrahepatic cholangiocarcinoma: a review of the general principles. Int J Surg. 82S, 77-81 (2020).
  5. Li, J., et al. Application of the laparoscopic technique in perihilar cholangiocarcinoma surgery. Int J Surg. 44, 104-109 (2017).
  6. Chen, Y., Xu, Y., Zhang, Y. Current status of laparoscopic radical hilar cholangiocarcinoma in Mainland China. Biosci Trends. 14 (3), 168-173 (2020).
  7. Xiong, F., Peng, F., Li, X., Chen, Y. Preliminary comparison of total laparoscopic and open radical resection for hepatic hilar cholangiocarcinoma: A single-center cohort study. Asian J Surg. 46 (2), 856-862 (2023).
  8. Cho, A., et al. Laparoscopy in the management of hilar cholangiocarcinoma. World J Gastroenterol. 20 (41), 15153-15157 (2014).
  9. Hu, M., et al. Efficacy and safety of robotic surgery versus open surgery for hilar cholangiocarcinoma: a systematic review and meta-analysis. Int J Surg. 111, 1301-1310 (2025).
  10. Balci, D., et al. Associating liver partition and portal vein ligation for staged hepatectomy (ALPPS) procedure for cholangiocarcinoma. Int J Surg. 82S, 97-102 (2020).
  11. Razumilava, N., Gores, G. J. Cholangiocarcinoma. Lancet. 383 (9935), 2168-2179 (2014).
  12. Hakkenbrak, N. A. G., Jansma, E. P., van der Wielen, N., van der Peet, D. L., Straatman, J. Laparoscopic versus open distal gastrectomy for gastric cancer: A systematic review and meta-analysis. Surgery. 171 (6), 1552-1561 (2022).
  13. Giannini, A., et al. The great debate: Surgical outcomes of laparoscopic versus laparotomic myomectomy. A meta-analysis to critically evaluate current evidence and look over the horizon. Eur J Obstet Gynecol Reprod Biol. 297, 50-58 (2024).
  14. Olij, B., et al. Health-related quality of life in patients undergoing laparoscopic versus open hemihepatectomy: a secondary analysis of the ORANGE II PLUS randomised controlled, phase 3, superiority trial. Lancet Reg Health Eur. 54, 101311(2025).
  15. Schildberg, C., et al. Laparoscopic appendectomy as the gold standard: What role remains for open surgery, conversion, and disease severity? An analysis of 32,000 cases with appendicitis in Germany. World J Emerg Surg. 20, 53(2025).
  16. Schmelzle, M. Small cuts, big impact: rethinking liver surgery. Lancet Reg Health Eur. 54, 101345(2025).
  17. Fichtinger, R. S., et al. Laparoscopic versus open hemihepatectomy: The ORANGE II PLUS multicenter randomized controlled trial. J Clin Oncol. 42 (15), 1799-1809 (2024).
  18. Schmelzle, M., et al. Robotic vs. laparoscopic liver surgery: a single-center analysis of 600 consecutive patients in 6 years. Surg Endosc. 36 (8), 5854-5862 (2022).
  19. Nagino, M., et al. One hundred consecutive hepatobiliary resections for biliary hilar malignancy: preoperative blood donation, blood loss, transfusion, and outcome. Surgery. 137 (2), 148-155 (2005).
  20. Ratti, F., et al. Perihilar cholangiocarcinoma: are we ready to step towards minimally invasiveness. Updates Surg. 72 (2), 423-433 (2020).
  21. Nagino, M., et al. Evolution of surgical treatment for perihilar cholangiocarcinoma: a single-center 34-year review of 574 consecutive resections. Ann Surg. 258 (1), 129-140 (2013).
  22. Tabata, M., Kawarada, Y., Yokoi, H., Higashiguchi, T., Isaji, S. Surgical treatment for hilar cholangiocarcinoma. J Hepatobiliary Pancreat Surg. 7, 148-154 (2000).
  23. Papoulas, M., et al. Contemporary surgical approach to hilar cholangiocarcinoma. Isr Med Assoc J. 13 (2), 99-103 (2011).
  24. Wang, D., et al. The value of total caudate lobe resection for hilar cholangiocarcinoma: a systematic review. Int J Surg. 110, 385-394 (2024).
  25. Tao, R., et al. Does caudate lobe resection really improve the surgical outcomes of patients with hilar cholangiocarcinoma? A multicenter retrospective study. Sci China Life Sci. 68 (7), 2106-2120 (2025).
  26. Nagino, M., et al. 34;Anatomic" right hepatic trisectionectomy (extended right hepatectomy) with caudate lobectomy for hilar cholangiocarcinoma. Ann Surg. 243 (1), 28-32 (2006).
  27. Bae, J., et al. Survival outcome of surgical resection compared to non-resection for Bismuth type IV perihilar cholangiocarcinoma. Langenbecks Arch Surg. 408 (1), 229(2023).
  28. Sasaki, R., et al. Impact of three-dimensional analysis of multidetector row computed tomography cholangioportography in operative planning for hilar cholangiocarcinoma. Am J Surg. 202 (4), 441-448 (2011).
  29. de Jong, M. C., et al. The impact of portal vein resection on outcomes for hilar cholangiocarcinoma: a multi-institutional analysis of 305 cases. Cancer. 118 (19), 4737-4747 (2012).
  30. Wang, S. T., et al. Combined vascular resection and analysis of prognostic factors for hilar cholangiocarcinoma. Hepatobiliary Pancreat Dis Int. 14 (6), 626-632 (2015).
  31. Christodoulou, M., Pattilachan, T., Ross, S. B., Larocca, S., Sucandy, I. Robotic left hepatectomy with en bloc biliary resection and Roux-en-Y hepaticojejunostomy: A technique of portal venous tangential vascular reconstruction. Ann Surg Oncol. 31 (8), 4905-4907 (2024).
  32. Yi, J., et al. Complete laparoscopic radical resection of perihilar cholangiocarcinoma type IIIb. J Vis Exp. (215), e67492(2025).

Access restricted. Please log in or start a trial to view this content.

Reprints and Permissions

Tags

Laparoscopic ResectionPortal Vein InvasionVascular ResectionHepatobiliary SurgeryLymph Node DissectionRoux en Y HepaticojejunostomyBile Duct ReconstructionMinimally Invasive SurgeryPostoperative Surveillance